Home ENGLISH Page 2

ENGLISH

Latest

Predicting the risk of heart disease, diabetes and more using millions of gene variants

admin -
0

Izana starts proof-of-concept trial for spinal arthritis drug

admin -
0

Fresh from GSK deal, Orchard raises $150M for multifront late-phase gene therapy push

admin -
0

MD Anderson, Accelerator bake up Magnolia, an NYC biotech in neuroprotection, with $31M series...

admin -
0

UC Berkeley backs oral gene therapy company targeting the gut in $1.5M seed round

admin -
0

Astellas absorbs U.K. ocular gene therapy player Quethera

admin -
0

Artios bags $84M to trial next-generation DNA damage response drugs

admin -
0

Could a glaucoma drug also fight obesity?

admin -
0

Vernalis, weakened by FDA rejections, accepts £33M Ligand bid 

admin -
0

Chutes & Ladders—Off-the-shelf CAR-T player Cellectis poaches Novartis executive

admin -
0

PARP inhibitors show promise for treating ALS and other brain disorders

admin -
0

Millendo plans to go public through OvaScience takeover, in push to complete late-stage R&D

admin -
0

Novo powers rare disease startup Therachon to $60M round

admin -
0

Sarepta builds in gene therapy with $30M Lacerta deal

admin -
0

Congressman charged in biotech insider trading case

admin -
0

Quick-fire fundraisings give Apexigen $73M for I-O push

admin -
0

How virus ‘clusters’ cause norovirus and other stomach bugs to spread

admin -
0

SQZ raises $72M as cell therapies close in on clinical trials

admin -
0
123...1,446Page 2 of 1,446
©